Stem Cell-Based Approaches for the Suppression of Inflammation and Fibrosis in Asherman's Syndrome: Biological Mechanisms and Clinical Evidence
DOI:
https://doi.org/10.52340/GBMN.2026.01.01.158Keywords:
Asherman's syndrome, endometrial regeneration, fibrosis, infertility, intrauterine adhesions, stem cell therapyAbstract
Asherman's syndrome is a complex gynecological disorder resulting from endometrial injury and a defective uterine repair mechanism. These complicated manifestations cause irregular menstruation, infertility, and poor reproductive outcomes. Treatment nowadays includes hysteroscopic adhesiolysis and hormonal therapy, and as medicine develops, many innovative and prognostically optimal approaches appear. Recently, stem cell-based therapies have demonstrated highly promising regenerative properties due to their immunomodulatory, antifibrotic, and pro-angiogenic effects. This review evaluates the biological mechanisms by which stem cell-based therapies may reduce inflammation and fibrosis in Asherman's syndrome and summarizes the current clinical evidence. A comprehensive search was conducted across PubMed, Scopus, ClinicalTrials.gov, and Google Scholar for studies published between 2010 and 2026. The sources of stem cells, distribution strategies, and suggested mechanisms of action were systematically analyzed. This review integrates clinical data to demonstrate how stem cell-based interventions modulate the inflammatory and fibrotic pathways in Asherman's syndrome and to identify key limitations that hinder their use in standardized therapies.References
March C. Asherman’s Syndrome. Semin Reprod Med. 2011;29(02):083-094. doi:10.1055/s-0031-1272470.
Bosteels J, van Wessel S, Weyers S, Broekmans FJ, D’Hooghe TM, Bongers MY, Mol BWJ. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database of Systematic Reviews. 2018;2018(12). doi:10.1002/14651858.CD009461.pub4.
Wang PH, Yang ST, Chang WH, Liu CH, Liu HH, Lee WL. Intrauterine adhesion. Taiwan J Obstet Gynecol. 2024;63(3):312-319. doi:10.1016/j.tjog.2024.02.004.
Hooker AB, de Leeuw RA, Twisk JWR, Brölmann HAM, Huirne JAF. Reproductive performance of women with and without intrauterine adhesions following recurrent dilatation and curettage for miscarriage: long-term follow-up of a randomized controlled trial. Human Reproduction. Published online December 15, 2020. doi:10.1093/humrep/deaa289.
Deans R, Abbott J. Review of Intrauterine Adhesions. J Minim Invasive Gynecol. 2010;17(5):555-569. doi:10.1016/j.jmig.2010.04.016.
Santamaria X, Cabanillas S, Cervelló I, Arbona C, Raga F, Ferro J, Palmero J, Remohí J, Pellicer A, Simón C. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Human Reproduction. 2016;31(5):1087-1096. doi:10.1093/humrep/dew042.
Gao F, Chiu SM, Motan DAL, Zhang Z, Chen L, Ji HL, Tse HF, Fu QL, Lian Q. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 2016;7(1):e2062-e2062. doi:10.1038/cddis.2015.327.
Guo S, Li W, Chen X, Liu M. Exploring the application value of ultrasound in animal studies of stem cell therapy for intrauterine adhesions. Sci Rep. 2025;15(1):29319. doi:10.1038/s41598-025-14996-9.
Cao Y, Wu J, Huang J, Fan X, Zhang Y, Li L, Dai Y. Human embryonic stem cell-derived immunity-and-matrix-regulatory cells promote endometrial repair and fertility restoration in IUA rats. Stem Cell Res Ther. 2025;16(1):204. doi:10.1186/s13287-025-04298-2.
Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9(1):63. doi:10.1186/s13287-018-0791-7.
Chen K, Gao Y, Xia N, Liu Y, Wang H, Ma H, Zheng S, Fang F. Long-term therapeutic effects of allogeneic mesenchymal stem cell transplantation for intrauterine adhesions. Stem Cell Res Ther. 2024;15(1):499. doi:10.1186/s13287-024-04100-9.
Masuda H, Schwab KE, Filby CE, Tan CSC, Tsaltas J, Weston GC, Gargett CE. Endometrial stem/progenitor cells in menstrual blood and peritoneal fluid of women with and without endometriosis. Reprod Biomed Online. 2021;43(1):3-13. doi:10.1016/j.rbmo.2021.04.008.
Gargett CE, Nguyen HPT, Ye L. Endometrial regeneration and endometrial stem/progenitor cells. Rev Endocr Metab Disord. 2012;13(4):235-251. doi:10.1007/s11154-012-9221-9.
Ruiz-Mitjana A, Navaridas R, Vidal-Sabanés M, Perramon-Güell A, Yeramian A, Felip I, Eritja N, Egea J, Encinas M, Matias-Guiu X, Dolcet X. Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition. Sci Rep. 2022;12(1):14821. doi:10.1038/s41598-022-18976-1.
Henderson NC, Rieder F, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587(7835):555-566. doi:10.1038/s41586-020-2938-9.
Stevens LJ, Page-McCaw A. A secreted MMP is required for reepithelialization during wound healing. Mol Biol Cell. 2012;23(6):1068-1079. doi:10.1091/mbc.e11-09-0745.
Leaf IA, Nakagawa S, Johnson BG, Cha JJ, Mittelsteadt K, Guckian KM, Gomez IG, Altemeier WA, Duffield JS. Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury. Journal of Clinical Investigation. 2016;127(1):321-334. doi:10.1172/JCI87532.
Zhao J, Wang Y, Ma C, Feng Y, Wang Y, Sun S. SCGB1D4 downregulation links to fibrosis in intrauterine adhesion patients and rat models. Biol Reprod. 2025;112(2):273-285. doi:10.1093/biolre/ioae172.
Meng X ming, Nikolic-Paterson DJ, Lan HY. TGF-β: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325-338. doi:10.1038/nrneph.2016.48.
Yao Y, Chen R, Wang G, Zhang Y, Liu F. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium. Stem Cell Res Ther. 2019;10(1):225. doi:10.1186/s13287-019-1332-8.
Saribas GS, Ozogul C, Tiryaki M, Alpaslan Pinarli F, Hamdemir Kilic S. Effects of uterus derived mesenchymal stem cells and their exosomes on asherman’s syndrome. Acta Histochem. 2020;122(1):151465. doi:10.1016/j.acthis.2019.151465.
Wu J, Wang J, Pei Z, Zhu Y, Zhang X, Zhou Z, Ye C, Song M, Hu Y, Xue P, Zhao G. Endothelial senescence induced by PAI-1 promotes endometrial fibrosis. Cell Death Discov. 2025;11(1):89. doi:10.1038/s41420-025-02377-0.
Rim EY, Clevers H, Nusse R. The Wnt Pathway: From Signaling Mechanisms to Synthetic Modulators. Annu Rev Biochem. 2022;91(1):571-598. doi:10.1146/annurev-biochem-040320-103615.
Boretto M, Cox B, Noben M, Hendriks N, Fassbender A, Roose H, Amant F, Timmerman D, Tomassetti C, Vanhie A, Meuleman C, Ferrante M, Vankelecom H. Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability. Development. 2017;144(10):1775-1786. doi:10.1242/dev.148478.
Mishra A, Modi D. Role of HOXA10 in pathologies of the endometrium. Rev Endocr Metab Disord. 2025;26(1):81-96. doi:10.1007/s11154-024-09923-8.
Günther V, Allahqoli L, Deenadayal-Mettler A, Maass N, Mettler L, Gitas G, Andresen K, Schubert M, Ackermann J, von Otte S, Alkatout I. Molecular Determinants of Uterine Receptivity: Comparison of Successful Implantation, Recurrent Miscarriage, and Recurrent Implantation Failure. Int J Mol Sci. 2023;24(24):17616. doi:10.3390/ijms242417616.
Fukui Y, Hirota Y, Saito-Fujita T, Aikawa S, Hiraoka T, Kaku T, Hirata T, Akaeda S, Matsuo M, Shimizu-Hirota R, Takeda N, Ikawa M, Osuga Y. Uterine Epithelial LIF Receptors Contribute to Implantation Chamber Formation in Blastocyst Attachment. Endocrinology. 2021;162(11). doi:10.1210/endocr/bqab169.
Gao L, Liang E, Zhang D, Zhang Y, Zhang X, Jiang G, Chen S, Li N, Wang X, Shen Y. Epigenetic alternations and targeted therapy in intrauterine adhesion: A comparative study. Genomics. 2023;115(5):110673. doi:10.1016/j.ygeno.2023.110673.
Handy DE, Castro R, Loscalzo J. Epigenetic Modifications. Circulation. 2011;123(19):2145-2156. doi:10.1161/CIRCULATIONAHA.110.956839.
Jhamat N, Niazi A, Guo Y, Chanrot M, Ivanova E, Kelsey G, Bongcam-Rudloff E, Andersson G, Humblot P. LPS-treatment of bovine endometrial epithelial cells causes differential DNA methylation of genes associated with inflammation and endometrial function. BMC Genomics. 2020;21(1):385. doi:10.1186/s12864-020-06777-7.
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178-196. doi:10.1038/nrm3758.
Zhou Z, Wang H, Zhang X, Song M, Yao S, Jiang P, Liu D, Wang Z, Lv H, Li R, Hong Y, Dai J, Hu Y, Zhao G. Defective autophagy contributes to endometrial epithelial-mesenchymal transition in intrauterine adhesions. Autophagy. 2022;18(10):2427-2442. doi:10.1080/15548627.2022.2038994.
Hernández-Melchor D. Improvement of endometrial thickness and in vitro fertilization outcomes in patients with Asherman’s refractory endometrium using autologous mesenchymal stem cells from the stromal vascular fraction. Am J Transl Res. 2024;16(8):4020-4031. doi:10.62347/UAGF1249.
Cao Y, Wu J, Huang J, Fan X, Zhang Y, Li L, Dai Y. Human embryonic stem cell-derived immunity-and-matrix-regulatory cells promote endometrial repair and fertility restoration in IUA rats. Stem Cell Res Ther. 2025;16(1):204. doi:10.1186/s13287-025-04298-2.
Semenza GL. Hypoxia-Inducible Factors in Physiology and Medicine. Cell. 2012;148(3):399-408. doi:10.1016/j.cell.2012.01.021.
Jiang A, Liu J, Wang Y, Zhang C. cGAS-STING signaling pathway promotes hypoxia-induced renal fibrosis by regulating PFKFB3-mediated glycolysis. Free Radic Biol Med. 2023;208:516-529. doi:10.1016/j.freeradbiomed.2023.09.011.
Shabanian S, Khazaie M, Ferns GA, Arjmand MH. Local renin-angiotensin system molecular mechanisms in intrauterine adhesions formation following gynecological operations, new strategy for novel treatment. J Obstet Gynaecol (Lahore). 2022;42(6):1613-1618. doi:10.1080/01443615.2022.2036972.
Parashar S, Pajai S, Tarang T. Recent Advancement in the Management of Intrauterine Adhesions Using Stem Cell Therapy: A Review Article. Cureus. Published online August 16, 2023. doi:10.7759/cureus.43553.
Lotfy A, AboQuella NM, Wang H. Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther. 2023;14(1):66. doi:10.1186/s13287-023-03287-7.
Liu H, Zhang X, Zhang M, Zhang S, Li J, Zhang Y, Wang Q, Cai JP, Cheng K, Wang S. Mesenchymal Stem Cell Derived Exosomes Repair Uterine Injury by Targeting Transforming Growth Factor-β Signaling. ACS Nano. 2024;18(4):3509-3519. doi:10.1021/acsnano.3c10884.
Hu J, Song K, Zhang J, Zhang Y, Tan B. Effects of menstrual blood derived stem cells on endometrial injury repair. Mol Med Rep. Published online December 12, 2018. doi:10.3892/mmr.2018.9744.
